Neuronetics, Inc

Neuronetics Unveils Major Updates to NeuroStar and TrakStar Software for Enhanced Patient Care and Data Management

MALVERN, PA — Neuronetics Inc. (NASDAQ: STIM) announced this week significant updates to its proprietary NeuroStar software and TrakStar® Patient Data Management System. These enhancements aim to revolutionize patient care …

Neuronetics Unveils Major Updates to NeuroStar and TrakStar Software for Enhanced Patient Care and Data Management Read More

Aclaris Therapeutics

Aclaris Therapeutics Halts Development of Rheumatoid Arthritis Drug After Phase 2b Study Misses Primary Endpoint

WAYNE, PA — Aclaris Therapeutics, Inc. (NASDAQ: ACRS) this week announced disappointing top-line results from a Phase 2b study of zunsemetinib (ATI-450) in patients with moderate to severe rheumatoid arthritis …

Aclaris Therapeutics Halts Development of Rheumatoid Arthritis Drug After Phase 2b Study Misses Primary Endpoint Read More



Verrica Pharmaceuticals Inc

Verrica Pharmaceuticals Announces Presentation at the Jefferies Global Healthcare Conference in London

WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) announced Ted White, Verrica President & Chief Executive Officer, will present at the upcoming Jefferies Global Healthcare Conference, which is being …

Verrica Pharmaceuticals Announces Presentation at the Jefferies Global Healthcare Conference in London Read More